855301-00-7 Usage
Uses
Used in Pharmaceutical Industry:
5-(2-Chlorophenyl)nicotinaldehyde is utilized as an intermediate for the synthesis of various drugs. Its unique chemical structure allows it to be a key component in the development of new pharmaceuticals, contributing to the advancement of medicinal chemistry.
Used in Agrochemical Industry:
In the agrochemical sector, 5-(2-Chlorophenyl)nicotinaldehyde serves as an intermediate in the production of crop protection products. Its role in this industry is crucial for the synthesis of compounds that protect crops from pests and diseases, thereby ensuring agricultural productivity.
Used as a Building Block in Organic Chemistry:
5-(2-Chlorophenyl)nicotinaldehyde is also employed as a building block in the creation of other organic compounds. Its chemical properties make it a valuable precursor for the synthesis of a wide array of organic molecules, expanding its utility in various chemical reactions and processes.
Check Digit Verification of cas no
The CAS Registry Mumber 855301-00-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,5,5,3,0 and 1 respectively; the second part has 2 digits, 0 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 855301-00:
(8*8)+(7*5)+(6*5)+(5*3)+(4*0)+(3*1)+(2*0)+(1*0)=147
147 % 10 = 7
So 855301-00-7 is a valid CAS Registry Number.
855301-00-7Relevant academic research and scientific papers
Inhibitors of HCV NS5B polymerase. Part 1: Evaluation of the southern region of (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid
Pfefferkorn, Jeffrey A.,Greene, Meredith L.,Nugent, Richard A.,Gross, Rebecca J.,Mitchell, Mark A.,Finzel, Barry C.,Harris, Melissa S.,Wells, Peter A.,Shelly, John A.,Anstadt, Robert A.,Kilkuskie, Robert E.,Kopta, Laurice A.,Schwende, Francis J.
, p. 2481 - 2486 (2007/10/03)
A novel series of nonnucleoside HCV NS5B polymerase inhibitors were prepared from (2Z)-2-(benzoylamino)-3-(5-phenyl-2-furyl)acrylic acid, a high throughput screening lead. SAR studies combined with structure based drug design focusing on the southern heterobiaryl region of the template led to the synthesis of several potent and orally bioavailable lead compounds. X-ray crystallography studies were also performed to understand the interaction of these inhibitors with HCV NS5B polymerase.
